Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
Míriam Mecha, Ana Feliú, Isabel Machín-Díaz, et al.
Glia (2018) Vol. 66, Iss. 7, pp. 1447-1463
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Mikiei Tanaka, Scott Sackett, Yumin Zhang
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 117
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 103
How to reprogram microglia toward beneficial functions
Marta Fumagalli, Marta Lombardi, Pierre Gressèns, et al.
Glia (2018) Vol. 66, Iss. 12, pp. 2531-2549
Open Access | Times Cited: 94
The cannabinoid system and microglia in health and disease
Samuel S. Duffy, Jessica P. Hayes, Nathan T. Fiore, et al.
Neuropharmacology (2021) Vol. 190, pp. 108555-108555
Closed Access | Times Cited: 71
Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
Gerwyn Morris, Adam J. Walker, Ken Walder, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 2158-2182
Closed Access | Times Cited: 61
Endocannabinoids in immune regulation and immunopathologies
Oindrila Rahaman, Dipyaman Ganguly
Immunology (2021) Vol. 164, Iss. 2, pp. 242-252
Open Access | Times Cited: 56
Regulatory Cells in Multiple Sclerosis: From Blood to Brain
Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano‐Regal, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 335-335
Open Access | Times Cited: 39
CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Wanda Grabon, Sylvain Rheims, Jonathon Smith, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105226-105226
Open Access | Times Cited: 27
Cannabinoid exposure during pregnancy and its impact on immune function
Catherine Dong, Jingwen Chen, Amy Harrington, et al.
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 4, pp. 729-743
Open Access | Times Cited: 71
Facets of Theiler’s Murine Encephalomyelitis Virus-Induced Diseases: An Update
Ingo Gerhauser, Florian Hansmann, Małgorzata Ciurkiewicz, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 448-448
Open Access | Times Cited: 64
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Ana Bernal‐Chico, Vanja Tepavčević, Andrea Manterola, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 103-126
Open Access | Times Cited: 29
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination
Victor Longoria, Hannah Parcel, Bameelia Toma, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 539-539
Open Access | Times Cited: 28
The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis
Carolina Melero‐Jerez, Aitana Alonso-Gómez, Esther Moñivas, et al.
Neurobiology of Disease (2020) Vol. 140, pp. 104869-104869
Open Access | Times Cited: 39
Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder
Mingyang Zou, Yu Liu, Shu Xie, et al.
Open Biology (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 34
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
Andrea Manterola, Ana Bernal‐Chico, Raffaela Cipriani, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 189-201
Open Access | Times Cited: 42
Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis
Leyre Mestre, Francisco Carrillo‐Salinas, Míriam Mecha, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 51-66
Closed Access | Times Cited: 39
The role of microglia in neuroprogressive disorders: mechanisms and possible neurotherapeutic effects of induced ketosis
Gerwyn Morris, Basant K. Puri, Michaël Maes, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 99, pp. 109858-109858
Closed Access | Times Cited: 36
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
Míriam Mecha, Francisco Carrillo‐Salinas, Ana Feliú, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 33
Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation
Carolina Melero‐Jerez, Beatriz Fernández‐Gómez, Rafael Lebrón‐Galán, et al.
Glia (2020) Vol. 69, Iss. 4, pp. 905-924
Open Access | Times Cited: 33
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
María Cristina Ortega, Rafael Lebrón‐Galán, Isabel Machín-Díaz, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 2, pp. 263-282
Open Access | Times Cited: 12
Research progress on the cannabinoid type-2 receptor and Parkinson’s disease
Xiao‐Qi Yu, Yi Jia, Yuan Dong
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 4
The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia
Míriam Mecha, Natalia Yanguas‐Casás, Ana Feliú, et al.
Brain Behavior and Immunity (2018) Vol. 77, pp. 110-126
Open Access | Times Cited: 34
The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer
Chongyang Qiu, Lei Yang, Botao Wang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 115, pp. 108952-108952
Open Access | Times Cited: 32
Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad
Yongtong Ge, Dalei Cheng, Qingzhi Jia, et al.
Immune Network (2021) Vol. 21, Iss. 3
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top